Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more. Readers will also gain a better understanding of the molecular and cellular events that underlie ovarian cancer immunology. This book is an ideal resource for clinicians, basic medical scientists, graduate basic medical science students, and medical students caring for patients with ovarian cancer, including attending surgeons and physicians, and clinical fellows and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology.

In an era of promising advances in cancer research, there are considerable and even alarming gaps in the fundamental knowledge and understanding of ovarian cancer. Researchers now know that ovarian cancer is not a single disease-several distinct subtypes exist with different origins, risk factors, genetic mutations, biological behaviors, and prognoses. However, persistent questions have impeded progress toward improving the prevention, early detection, treatment, and management of ovarian cancers. Failure to significantly improve morbidity and mortality during the past several decades is likely due to several factors, including the lack of research being performed by specific disease subtype, lack of definitive knowledge of the cell of origin and disease progression, and incomplete understanding of genetic and non-genetic risk factors. Ovarian Cancers examines the state of the science in ovarian cancer research, identifies key gaps in the evidence base and the challenges to addressing those gaps, considers opportunities for advancing ovarian cancer research, and examines avenues for translation and dissemination of new findings and communication of new information to patients and others. This study makes recommendations for public- and private-sector efforts that could facilitate progress in reducing the incidence of morbidity and mortality from ovarian cancers.

"Ovarian Cancer: A Comprehensive Resource for Patients and Families" is a vital guide for anyone impacted by ovarian cancer. This book provides a thorough exploration of the disease, offering clarity and support through each stage, from initial diagnosis to treatment and beyond.Understanding Ovarian CancerThe journey begins with an introduction to ovarian cancer, including its epidemiology, types, and stages. Gain an understanding of the ovaries' role in the female reproductive system and how cancer affects these vital organs.Recognizing Risk Factors and Early DetectionLearn about the genetic and environmental risk factors associated with ovarian cancer and the importance of early detection. This book covers the challenges of early detection, screening methods, and the critical role of diagnostic testing.Navigating Diagnosis and TreatmentDelve into the diagnostic process, including understanding pathology reports and the role of biopsy. Explore comprehensive treatment options, from surgery to chemotherapy, radiotherapy, and the latest in targeted therapy and immunotherapy.Managing Side Effects and ComplicationsUnderstand and manage the side effects and complications associated with treatment, including pain management and coping with emotional and physical stress.Nutrition and Lifestyle during TreatmentDiscover the importance of nutrition and lifestyle changes during treatment, with practical advice on diet, exercise, and lifestyle modifications for optimal health.Psychological Impact and SupportFind guidance on coping with the emotional and psychological impacts of ovarian cancer. Learn about the importance of psychological support, counseling, and the role of community and support groups.Recurrence and Long-term ManagementAddress the challenges of recurrence and long-term management of ovarian cancer, including strategies for monitoring, follow-up care, and understanding recurrence.Advances in ResearchStay informed about the latest advances in ovarian cancer research, emerging treatments, and the future direction of care and clinical trials.Special Considerations in CareGain insights into special considerations for ovarian cancer care, including issues relevant to young women, fertility, and menopausal management post-treatment.Advocacy and AwarenessUnderstand the importance of raising awareness and advocacy for ovarian cancer. Discover support networks and resources available to empower patients and families."Ovarian Cancer: A Comprehensive Resource for Patients and Families" is an indispensable tool, offering comfort, clarity, and hope to those navigating the complexities of ovarian cancer. It is a comprehensive guide that not only provides medical information but also addresses the emotional and practical aspects of coping with the disease.

'Ovarian Cancer Immunotherapy' provides a broad overview of several aspects of basic sciences and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more.

Overcoming Ovarian Cancer Chemoresistance presents non-overlapping review chapters that discuss the state of the field in overcoming chemoresistance of ovarian cancer and treatment options before and following recurrence, considering the genetic makeup of the ovarian cancer patient and her tumor. With the uptake of both germline and somatic gene testing, clinicians can obtain a more comprehensive understanding of ovarian tumors and this book provides information to link the genetic makeup of a tumor (or patient) with the best available treatment. The book discusses topics such as strategies to fight chemo-resistance in ovarian cancer, circulating DNA as a monitor of response, BRCA mutations, ovarian cancer stem cells, immunotherapy and vaccines. Additionally, it brings a list of promising agents at clinical and pre-clinical stage that will impact the treatment in the near future. This book is a valuable source for cancer researchers, oncologists and several members of biomedical field who need to understand how to battle chemoresistance in ovarian cancer. Provides a comprehensive view of both biological and genetic determinants of resistance, as well as technical approaches to monitor response Discusses genetic reversions as a unique alteration and a new field of study Includes a chapter on upcoming and promising agents that are in the pre-clinical and early clinical space, to set the stage for future directions in the field

Holland-Frei Cancer Medicine, Ninth Edition, offers a balanced view of the most current knowledge of cancer science and clinical oncology practice. This all-new edition is the consummate reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients. A translational perspective throughout, integrating cancer biology with cancer management providing an in depth understanding of the disease An emphasis on multidisciplinary, research-driven patient care to improve outcomes and optimal use of all appropriate therapies Cutting-edge coverage of personalized cancer care, including molecular diagnostics and therapeutics Concise, readable, clinically relevant text with algorithms, guidelines and insight into the use of both conventional and novel drugs Includes free access to the Wiley Digital Edition providing search across the book, the full reference list with web links, illustrations and photographs, and post-publication updates

Updated and expanded, the third edition of Surgery for Ovarian Cancer focuses on essential techniques for the effective management of ovarian cancer. It reflects the most contemporary science and surgical applications for the management of patients with ovarian cancer and related peritoneal surface malignancies. This new edition takes a step-by-step approach and includes new intraoperative photographs and videos illustrating surgical procedures. It is principally devoted to the technical aspects of cytoreductive surgery, with chapters divided according to anatomic region. The chapters cover relevant anatomical considerations, surgical challenges specific to each region, and operative approaches and techniques favored by the authors. The list of contributing authors has been expanded from the previous edition and includes international and world-renowned experts from the fields of gynecologic oncology and surgical oncology. The topics of minimally invasive surgery, secondary cytoreduction, palliative surgery, and postoperative care are also covered in detail. New to the third edition are chapters on preoperative risk stratification, regional therapeutics and peritonectomy procedures, and quality assurance relating to ovarian cancer surgery. This comprehensive text is essential reading for all practitioners working with patients with ovarian cancers.